Mariam Alexander, Thoracic Medical Oncologist at MUSC Health University Medical Center, shared a post on X:
“More options for this rare disease. Would this work after zipalertinib (trial patient)? FDA grants accelerated approval to sunvozertinib for NSCLC with EGFR exon 20 insertion mutation.”
More posts featuring Mariam Alexander.